Computed Tomogram Myocardial Thickness Map Guided pulmOnary Vein iSolaTion vs. Empirical Pulmonary Vein Isolation in Cryoballoon Ablation for Paroxysmal Atrial Fibrillation (UTMOST AF II)
NCT03912324 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2024-06-13
Summary
New parameters or methods, such as ablation index, have been developed for the quantification of high-frequency energy used in pulmonary vein isolation, but there is no known method for atrial fibrillation considering individual differences in atrial tissue. The atrium is only 1/3 of the thickness of the ventricle and is thinner in women and older than men or young people.
The aim of this study was to evaluate the efficacy and safety of radiofrequency energy therapy using atrial individual differences. In order to reflect the thickness of the atrium, we will use the unipolar and bipolar maps and the myocardial thickness map using computed tomography (CT) images. To evaluate the efficacy and safety of energy titration therapy by random assignment of high frequency energy therapy group, CT image application high frequency energy therapy group, and existing empirical high frequency therapy group.
Conditions
- Paroxysmal Atrial Fibrillation
Interventions
- PROCEDURE
-
Unipolar voltage subtraction map guided PV isolation group
1. Pulmonary vein isolation will be performed using a radiofrequency catheter 2. Esophageal temperature will be monitored to prevent esophageal injury 3. Mapping of echocardiographic unipolar voltage subtraction after atrial septal puncture 4. the electrode map data is transferred to the core lab by network to calculate the unipolar voltage subtraction color map (within 10 minutes) 5. Increase radiofrequency ablation time by 2 to 5 seconds in areas with high potential in unipolar voltage subtraction color map 6. Decrease radiofrequency ablation time by 2 to 5 seconds in areas with low potential in unipolar voltage subtraction color map 7. Evaluation of success rate and time of pulmonary vein isolation after bilateral pulmonary vein primary columnar resection 8. Evaluate time to complete isolation after additional ablation 9. Evaluation of Procedure and Ablation time, and perfusion saline dose 10. Rhythm follow-up after the procedure in accordance with the study design.
- PROCEDURE
-
CT myocardial thickness map guided PV isolation group
1. Pulmonary vein isolation will be performed using a radiofrequency catheter 2. Esophageal temperature will be monitored to prevent esophageal injury. 3. Prepared myocardial thickness map with CT DICOM images conducted prior to procedure. 4. Increase radiofrequency ablation time by 2 to 5 seconds in thick areas in CT myocardial thickness map 5. Decrease radiofrequency ablation time by 2 to 5 seconds in thin areas in CT myocardial thickness map 6. Evaluation of success rate and time of pulmonary vein isolation after bilateral pulmonary vein primary columnar resection 7. Evaluate time to complete isolation after additional ablation 8. Evaluation of Procedure time, Ablation time, and perfusion saline dose 9. Rhythm follow-up will be performed after the procedure in accordance with the aforementioned study design.
- PROCEDURE
-
Empirical PV isolation group
1. Pulmonary vein isolation will be performed using a radiofrequency catheter 2. Esophageal temperature will be monitored to prevent esophageal injury. 3. The procedure is performed by adjusting radiofrequency energy according to the traditional method and experience of the practitioner. 4. Evaluation of success rate and time of pulmonary vein isolation after bilateral pulmonary vein primary columnar resection 5. Evaluate time to complete isolation after additional ablation 6. Evaluation of Procedure time, Ablation time, and perfusion saline dose 7. Rhythm follow-up will be performed after the procedure in accordance with the aforementioned study design.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-06
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Randomized Trial: High Power Short Duration Versus Ablation Index
NCT05251545 ·Status: COMPLETED ·Phase: NA
-
Ablation Index Guided High Power Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation
NCT04379557 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation
NCT06557876 ·Status: RECRUITING ·Phase: NA
-
FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT02703454 ·Status: TERMINATED ·Phase: NA
-
A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial Fibrillation
NCT00434694 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
NCT04497376 ·Status: COMPLETED ·Phase: NA
-
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
NCT05940597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Reduction of Radiation Dose and Contrast Use During Cryoballoon Pulmonary Vein Isolation
NCT03786822 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation
NCT06878924 ·Status: NOT_YET_RECRUITING
-
High-density Mapping-guided bOx Isolation and subsTrate Ablation
NCT03998956 ·Status: UNKNOWN ·Phase: NA
-
PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF)
NCT00774566 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy
NCT00773539 ·Status: UNKNOWN ·Phase: PHASE4
-
Simplified Pulmonary Vein Isolation Using singLe Catheter and IntraCardiac Echocardiography
NCT04923009 ·Status: UNKNOWN ·Phase: PHASE4
-
Wide Area Circumferential Ablation With Contact Force Versus Cryoballoon Ablation
NCT03564925 ·Status: UNKNOWN ·Phase: NA
-
Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF
NCT06199180 ·Status: RECRUITING ·Phase: NA
-
INtra-procedural ultraSound Imaging During Pulmonary Veins Isolation
NCT03372798 ·Status: COMPLETED
-
Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective Registry
NCT03389074 ·Status: UNKNOWN
-
Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation
NCT03514693 ·Status: UNKNOWN ·Phase: NA
-
Outcomes of High Power Application in Catheter Ablation of Paroxysmal Atrial Fibrillation Guided by Unipolar Signal Modification.
NCT04447300 ·Status: UNKNOWN ·Phase: NA
-
Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter
NCT01710150 ·Status: WITHDRAWN ·Phase: NA
-
Incidence and Duration of Unintentional Neuromodulation Effects After Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
NCT05677516 ·Status: UNKNOWN
-
Ultra-High-Resolution Mapping Guided Partial Antral Ablation for AF
NCT03759912 ·Status: TERMINATED
-
Left Atrial Arrhythmia Substrate Identification After Confirmed durABLE Pulmonary Vein Isolation
NCT04111731 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Vein (PV) -Isolation: Arrhythmogenic Vein(s) Versus All Veins
NCT00605748 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus Block in Patients With Paroxysmal Atrial Fibrillation
NCT02019407 ·Status: COMPLETED ·Phase: NA